|
|
 |
|
Total Number of Holdings (excluding cash): 50
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
3,577 |
$90,251.01 |
2.94% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,896 |
$87,329.28 |
2.84% |
| Revvity, Inc. |
RVTY |
714046109 |
657 |
$84,417.93 |
2.75% |
| Baxter International Inc. |
BAX |
071813109 |
3,441 |
$82,102.26 |
2.67% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
229 |
$81,340.80 |
2.65% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
6,834 |
$80,625.24 |
2.62% |
| DexCom, Inc. |
DXCM |
252131107 |
921 |
$77,990.28 |
2.54% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
211 |
$77,764.05 |
2.53% |
| Olympus Corporation |
7733.JP |
J61240107 |
6,040 |
$77,693.18 |
2.53% |
| LivaNova Plc |
LIVN |
G5509L101 |
940 |
$75,792.20 |
2.47% |
| Waters Corporation |
WAT |
941848103 |
184 |
$75,441.84 |
2.46% |
| Agilent Technologies, Inc. |
A |
00846U101 |
513 |
$75,308.40 |
2.45% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
864 |
$75,185.28 |
2.45% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
118 |
$72,407.16 |
2.36% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
255 |
$71,627.10 |
2.33% |
| Becton, Dickinson and Company |
BDX |
075887109 |
382 |
$69,871.62 |
2.27% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,939 |
$67,795.46 |
2.21% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,616 |
$65,473.70 |
2.13% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$65,356.72 |
2.13% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
757 |
$64,738.64 |
2.11% |
| Teleflex Incorporated |
TFX |
879369106 |
498 |
$64,889.40 |
2.11% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
552 |
$64,384.22 |
2.10% |
| Medtronic Plc |
MDT |
G5960L103 |
676 |
$63,408.80 |
2.06% |
| Danaher Corporation |
DHR |
235851102 |
310 |
$63,007.50 |
2.05% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
295 |
$62,676.79 |
2.04% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
633 |
$61,109.82 |
1.99% |
| Abbott Laboratories |
ABT |
002824100 |
588 |
$60,616.92 |
1.97% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,332 |
$59,968.65 |
1.95% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
45 |
$57,858.75 |
1.88% |
| ResMed Inc. |
RMD |
761152107 |
258 |
$57,531.42 |
1.87% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
877 |
$56,785.14 |
1.85% |
| Penumbra, Inc. |
PEN |
70975L107 |
178 |
$56,935.08 |
1.85% |
| Steris Plc |
STE |
G8473T100 |
265 |
$56,619.90 |
1.84% |
| Align Technology, Inc. |
ALGN |
016255101 |
340 |
$52,020.00 |
1.69% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
807 |
$51,849.75 |
1.69% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,073 |
$51,847.12 |
1.69% |
| Alcon Inc. |
ALC.SW |
H01301128 |
756 |
$50,868.60 |
1.66% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
3,516 |
$49,768.15 |
1.62% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
652 |
$49,402.04 |
1.61% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
130 |
$49,132.20 |
1.60% |
| Stryker Corporation |
SYK |
863667101 |
174 |
$49,045.38 |
1.60% |
| Cochlear Limited |
COH.AU |
Q25953102 |
484 |
$47,147.03 |
1.53% |
| BioMerieux |
BIM.FP |
F1149Y232 |
558 |
$46,101.05 |
1.50% |
| The Cooper Companies, Inc. |
COO |
216648501 |
828 |
$44,894.16 |
1.46% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$44,555.07 |
1.45% |
| Boston Scientific Corporation |
BSX |
101137107 |
955 |
$43,022.75 |
1.40% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$42,711.35 |
1.39% |
| Insulet Corporation |
PODD |
45784P101 |
300 |
$41,340.00 |
1.35% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
514 |
$41,515.78 |
1.35% |
| US Dollar |
$USD |
|
12,876 |
$12,875.59 |
0.42% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|